Acute Effects of Legume-enriched Meals Compared to Western Diet Meals on Postprandial Metabolism in Participants With Increased Cardiometabolic Risk (LeguPlan_1)

April 12, 2024 updated by: Prof. Dr. Sarah Egert, University of Bonn

Acute Effects of Legume-enriched Meals Compared to Western Diet Meals on Postprandial Metabolic Response in Women and Men at Increased Risk of Cardiovascular and Neurodegenerative Diseases

The aim of the study is to investigate the postprandial effects of legume-enriched meals compared to Western Diet meals on postprandial metabolism. In this context, older adults with increased risk for cardiometabolic diseases consume 4 mixed meals with 36 g or 62 g of protein either designed according to the Planetary Health Diet with legumes as primary protein source or the Western Diet with animal foods as primary protein source, in a randomized order. In a postprandial observation period of 6 hours, parameters of lipid metabolism, glucose and insulin metabolism, amino acid profile, as well as markers of inflammation and vascular function are analysed. Furthermore, neuropsychological parameters and satiety-associated hormones are investigated.

Study Overview

Detailed Description

In a randomized crossover design, 30 older men and women with increased risk for cardiometabolic diseases consume 4 mixed meals, which differ in dietary pattern, protein source and protein quantity. Two meals are designed according to the Planetary Health Diet with legumes as primary protein source whereas the other two meals are designed according to the Western Diet with animal food as primary protein source. Two meals are designed as high protein meals (62 g of protein) and two meals are designed as low protein meals (36 g of Protein). Therefore, participants consume 4 different test meals, a Low and a High Protein Western Diet Meal and a Low and a High Protein Planetary Health Diet Meal in a randomized order. During a postprandial observation period of 6 hours, parameters of lipid metabolism (e.g., plasma triglycerides), glucose metabolism (e.g., plasma glucose, serum insulin), as well as markers of inflammation (e.g., IL-6) and vascular function (e.g., pulse wave velocity) are analysed. Furthermore, amino acid profile, neuropsychologic parameters (e.g., appetite) and satiety-associated hormones (e.g., Ghrelin) are investigated. Each intervention will be separated by a washout period of approximately 14 days.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North-Rhine Westphalia
      • Bonn, North-Rhine Westphalia, Germany, 53115
        • Recruiting
        • University of Bonn, Institute of Nutritional and Food Sciences, Nutrition Physiology
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • written informed consent
  • Non-smoking
  • BMI: 27 - 34,9 kg/m2
  • Waist circumference (women ≥ 80 cm, men ≥ 94 cm)
  • Systolic blood pressure: ≥ 120 mmHg, diastolic blood pressure: ≥ 80 mmHg
  • At least one of the following criteria
  • Fasting triglycerides in serum: ≥ 150 mg/dL
  • Fasting HDL-Cholesterol in serum: women < 50 mg/dl, men < 40 mg/dL
  • Fasting C-reactive protein in serum: ≥ 2 mg/L
  • Fasting glucose in plasma: ≥ 100 mg/dL

Exclusion Criteria:

  • food intolerances and allergies (especially to legumes)
  • Smoking
  • malabsorption syndromes
  • thyroid diseases
  • impaired renal function
  • chronic liver disease
  • heart failure
  • myocardial infarction
  • insulin-dependent diabetes mellitus
  • chronic inflammatory diseases
  • tumors
  • anemia
  • immunosuppression
  • intake of supplements (e.g., fish oil)
  • Participation in another study
  • other exclusion criteria at the discretion of the physician/ investigator

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Protein Planetary Health Diet
High Protein Planetary Health Diet Meal: This meal contains 62 g of protein primarily from plant origin (particularly legumes)
Planetary Health Diet Meal with 62 g of protein primarily from plant origin
Experimental: Low Protein Planetary Health Diet
Low Protein Planetary Health Diet Meal: This meal contains 36 g of protein from primarily plant origin (particularly legumes)
Planetary Health Diet Meal with 36 g of protein primarily from plant origin
Experimental: High Protein Western Diet
High Protein Western Diet Meal: This meal contains 62 g of protein primarily form animal origin
Western Diet Meal with 62 g of protein primarily from animal origin
Experimental: Low Protein Western Diet
Low Protein Western Diet Meal: This meal contains 36 g of protein primarily from animal origin
Western Diet Meal with 36 g of protein primarily from animal origin

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parameters of lipid metabolism in blood
Time Frame: Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Triglycerides (mg/dL)
Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parameters of lipid metabolism in blood
Time Frame: Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Total cholesterol (mg/dL)
Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Parameters of lipid metabolism in blood
Time Frame: Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
LDL cholesterol (mg/dL)
Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Parameters of lipid metabolism in blood
Time Frame: Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
HDL cholesterol (mg/dL)
Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Parameters of lipid metabolism in blood
Time Frame: Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Free fatty acids (mmol/L)
Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Parameters of glucose metabolism in blood
Time Frame: Postprandial period of 6 hours (T=0, 0.5, 1, 1.5, 2, 3, 4, 6 hours)
Glucose (mg/dL)
Postprandial period of 6 hours (T=0, 0.5, 1, 1.5, 2, 3, 4, 6 hours)
Parameters of glucose metabolism in blood
Time Frame: Postprandial period of 6 hours (T=0, 0.5, 1, 1.5, 2, 3, 4, 6 hours)
Insulin (nmol/L)
Postprandial period of 6 hours (T=0, 0.5, 1, 1.5, 2, 3, 4, 6 hours)
Parameters of glucose metabolism in blood
Time Frame: Postprandial period of 6 hours (T=0, 0.5, 1, 1.5, 2, 3, 4, 6 hours)
cPeptide (pg/mL)
Postprandial period of 6 hours (T=0, 0.5, 1, 1.5, 2, 3, 4, 6 hours)
Parameters of glucose metabolism in blood
Time Frame: Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
GLP-1 (pg/mL)
Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Parameters of glucose metabolism in blood
Time Frame: Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Glucagon (pg/mL)
Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Blood amino acid profile
Time Frame: Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Amino acid profile in blood (nmol/mL)
Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Blood urea
Time Frame: Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Urea in blood (mg/dL)
Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Uric acid in blood
Time Frame: Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Uric acid in blood (mg/dL)
Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Parameters of hunger and satiety in blood
Time Frame: Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
e.g. Ghrelin (pg/mL)
Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Parameters of endothelial function in blood
Time Frame: Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
e.g. ADMA (µmo/L)
Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Parameters of inflammation in blood
Time Frame: Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
e.g. IL-6 (pg/mL)
Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Endothelial function
Time Frame: Postprandial period of 6 hours (T=0, 2, 4, 6 hours)
e.g. pulse wave velocity (m/s)
Postprandial period of 6 hours (T=0, 2, 4, 6 hours)
Neuropsychological parameters
Time Frame: Postprandial period of 6 hours (T=0, 0.5, 1, 1.5, 2, 3, 4, 5, 6 hours)
Assessment of hunger and satiety via a visual analogue scale (e.g. 0 = not hungry at all to 10 = very hungry)
Postprandial period of 6 hours (T=0, 0.5, 1, 1.5, 2, 3, 4, 5, 6 hours)
Neuropsychological parameters
Time Frame: Postprandial period of 4.5 hours (T= 0, 1.5, 3, 4.5 hours)
Assessment of attention via questionnaire (paper pencil test, e.g. higher amount of marked target items = higher attention, maximum points 640 = every target items marked correctly, minimum points: 0 = no target items marked or only wrong items marked)
Postprandial period of 4.5 hours (T= 0, 1.5, 3, 4.5 hours)
Neuropsychological parameters
Time Frame: Postprandial period of 6 hours (T=0.5, 3, 6 hours)
Assessment of memory via questionnaire (paper pencil, e.g. higher reproduction of memorised visual and verbal information = better memory; visual part: maximum points: 31 = all visual information memorised, minimum points: 0 = no visual information memorised; verbal part: maximum points: 24 = all verbal information memorised, minimum points: 0 = no verbal information memorised)
Postprandial period of 6 hours (T=0.5, 3, 6 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

July 30, 2024

Study Completion (Estimated)

July 30, 2024

Study Registration Dates

First Submitted

February 2, 2024

First Submitted That Met QC Criteria

February 13, 2024

First Posted (Actual)

February 21, 2024

Study Record Updates

Last Update Posted (Estimated)

April 15, 2024

Last Update Submitted That Met QC Criteria

April 12, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on High Protein Planetary Health Diet

3
Subscribe